Thiogenesis Therapeutics Corp (TTI) Cash flow

5 Followers

Thiogenesis Therapeutics Corp Cash Flow

TSE:TTI's free cash flow for Q3 2024 was $-834.90K. For the 2024 fiscal year, TSE:TTI's free cash flow was decreased by $-1.16M and operating cash flow was $-834.90K. See a summary of the company’s cash flow.

Cash Flow	Dec 23	Dec 22	Feb 22	Feb 21	Dec 20
Operating Cash Flow	$ -3.25M	$ -2.09M	$ -67.08K	$ -35.88K	$ -373.04K
Investing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
Financing Cash Flow	$ ―	$ ―	$ ―	$ ―	$ ―
End Cash Position	$ ―	$ ―	$ ―	$ ―	$ ―
Free Cash Flow	$ -3.25M	$ -2.09M	$ -67.08K	$ -35.88K	$ -373.04K